These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7463112)

  • 1. A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms.
    Burchiel KJ; Schmer G
    J Neurosurg; 1981 Jan; 54(1):12-5. PubMed ID: 7463112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of plasma fibrinolytic activity in patients with ruptured intracranial aneurysms who are receiving epsilon-aminocaproic acid: relationship of possible complications of therapy to the degree of fibrinolytic inhibition.
    Burchiel KJ; Hoffman JM; Bakay RA
    Neurosurgery; 1984 Jan; 14(1):57-63. PubMed ID: 6537999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epsilon-aminocaproic acid and recurrent subarachnoid hemorrhage: a clinical trial.
    Shucart WA; Hussain SK; Cooper PR
    J Neurosurg; 1980 Jul; 53(1):28-31. PubMed ID: 7411206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm.
    Ramirez-Lassepas M
    Neurology; 1981 Mar; 31(3):316-22. PubMed ID: 7010208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory investigation of the effects of epsilon-aminocaproic acid on hemostasis.
    Green D; Ts'ao CH; Cerullo L; Cohen I; Ruo TI; Atkinson AJ
    J Lab Clin Med; 1985 Mar; 105(3):321-7. PubMed ID: 2982982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antifibrinolytic treatment after subarachnoid hemorrhage].
    Marchel A
    Neurol Neurochir Pol; 1992; 26(4):502-10. PubMed ID: 1484577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic activity in blood and cerebrospinal fluid in subarachnoid hemorrhage from ruptured intracranial saccular aneurysm before and during EACA treatment.
    Filizzolo F; D'angelo V; Collice M; Ferrara M; Donati MB; Porta M
    Eur Neurol; 1978; 17(1):43-7. PubMed ID: 624294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms.
    Sengupta RP; So SC; Villarejo-Ortega FJ
    J Neurosurg; 1976 Apr; 44(4):479-84. PubMed ID: 1255236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral complication of antifibrinolytic therapy in the treatment of ruptured intracranial aneurysm. Animal experiment and a review of literature.
    Yamaura A; Nakamura T; Makino H; Hagihara Y
    Eur Neurol; 1980; 19(2):77-84. PubMed ID: 6893025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifibrinolytic therapy in aneurysmal subarachnoid hemorrhage increases the risk for deep venous thrombosis: A case-control study.
    Foreman PM; Chua M; Harrigan MR; Fisher WS; Tubbs RS; Shoja MM; Griessenauer CJ
    Clin Neurol Neurosurg; 2015 Dec; 139():66-9. PubMed ID: 26378393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing the risk of rebleeding before early aneurysm surgery: a possible role for antifibrinolytic therapy.
    Leipzig TJ; Redelman K; Horner TG
    J Neurosurg; 1997 Feb; 86(2):220-5. PubMed ID: 9010423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy.
    Spallone A
    Acta Neurochir (Wien); 1982; 63(1-4):245-50. PubMed ID: 6179402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity.
    Alvarez Garijo JA; Vilches JJ; Aznar JA
    J Neurosurg; 1980 Apr; 52(4):453-5. PubMed ID: 7373370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report.
    Tubbs RR; Benjamin SP; Dohn DE
    J Neurosurg; 1979 Jul; 51(1):94-7. PubMed ID: 448423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrinolytic treatment in the pre-operative management of subarachnoid haemorrhage caused by ruptured intracranial aneurysm.
    Ameen AA; Illingworth R
    J Neurol Neurosurg Psychiatry; 1981 Mar; 44(3):220-6. PubMed ID: 7229645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a protocol for acute antifibrinolytic therapy on aneurysm rebleeding after subarachnoid hemorrhage.
    Starke RM; Kim GH; Fernandez A; Komotar RJ; Hickman ZL; Otten ML; Ducruet AF; Kellner CP; Hahn DK; Chwajol M; Mayer SA; Connolly ES
    Stroke; 2008 Sep; 39(9):2617-21. PubMed ID: 18658042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of antifibrinolytic, edema-preventing and hypotensive agents in the prevention of recurrent bleeding from intracranial aneurysms].
    Bromowicz J; Bryniarska D; Koniar-Danilewicz H; Danilewicz B
    Neurol Neurochir Pol; 1979; 13(6):647-51. PubMed ID: 514441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage.
    Nibbelink DW; Torner JC; Henderson WG
    Stroke; 1975; 6(6):622-9. PubMed ID: 1198627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Streptokinase clot lysis time in patients with ruptured intracranial aneurysms.
    Geronemus R; Herz DA; Shulman K
    J Neurosurg; 1974 Apr; 40(4):499-503. PubMed ID: 4814382
    [No Abstract]   [Full Text] [Related]  

  • 20. Myoglobinuria following epsilon-aminocaproic acid (EACA) therapy. Case report.
    Brodkin HM
    J Neurosurg; 1980 Nov; 53(5):690-2. PubMed ID: 7431078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.